D. Lee, K. Girgis, J. DeLorenzo, M. Neuwirth, A. Salemi, S. Waxman
{"title":"800.12 经导管主动脉瓣置换术(TAVR)后患者的抗血小板疗法(APT)与出血风险不一致与较高的出血率有关","authors":"D. Lee, K. Girgis, J. DeLorenzo, M. Neuwirth, A. Salemi, S. Waxman","doi":"10.1016/j.jcin.2024.01.237","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14666,"journal":{"name":"JACC: Cardiovascular Interventions","volume":"443 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"800.12 Incongruence of Antiplatelet Therapy (APT) with Bleeding Risk in Patients After Transcatheter Aortic Valve Replacement (TAVR) Is Associated with Higher Bleeding\",\"authors\":\"D. Lee, K. Girgis, J. DeLorenzo, M. Neuwirth, A. Salemi, S. Waxman\",\"doi\":\"10.1016/j.jcin.2024.01.237\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":14666,\"journal\":{\"name\":\"JACC: Cardiovascular Interventions\",\"volume\":\"443 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC: Cardiovascular Interventions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jcin.2024.01.237\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC: Cardiovascular Interventions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jcin.2024.01.237","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
800.12 Incongruence of Antiplatelet Therapy (APT) with Bleeding Risk in Patients After Transcatheter Aortic Valve Replacement (TAVR) Is Associated with Higher Bleeding